Bianual scholarships

Biannual grant for the study of colorectal cancer in terms of carcinogenesis mechanisms, prevention factors, disease progression, identification of new molecular lines, assessment of molecular variables to drug response, epidemiology, prognostic pathological factors, chemoprevention and new therapeutic approaches.

Grants granted:

2018/2019


Type A. Established researchers

Dr. Laura Valle Velasco

Institut Català d’Oncologia Institut d’Investigació Biomèdica de Bellvitge. ICO/IDIBELL.  L’Hospitalet de Llobregat

“Platform based on CRISPR/Cas-9-edited organoids for the functional evaluation of gene variants in colorectal cancer”

Total amount: 60.000 €


Type B. Emerging researchers

Dr. Ceres Fernández Rozadilla

Fundacion Pública Galega de Medicina Xenómica. Santiago de Compostela

“Novel liquid biopsy approaches to improve screening strategies for colorectal polyps and cancer”

Total amount: 60.000 €

2017/2018


Type A. Established researchers

Dr. Manel Esteller Badosa

Institut d’Investigació Biomèdica de Bellvitge. IDIBELL. L’Hospitalet de Llobregat

“Bioinformatic prediction of chemosensitive profiles in colorectal cancer using Epigenomics”

Total amount: 60.000 €


Type B. Emerging researchers

Dr. Rodrigo de Almeida Toledo

Institut d’Investigació Oncològica Vall d’Hebron. VHIO. Barcelona

“Evaluation of clonal evolution and changes in molecular dynamics evolution of colorectal cancers in patient’s blood”

Total amount: 60.000 €

2016/2017


Type A. Established researchers

Dr. Eduard Batlle Gómez

Institute for Research in Biomedicine (IRB Barcelona)

“Evaluating immunotherapies in a preclinical model of metastatic colorectal cancer”

Total amount: 60.000 €


Type B. Emerging researchers

Dr. Francesco Paolo Marchese

Center of Applied Medicine. CIMA. Navarra University. Pamplona.

“Long noncoding RNAs as therapeutic targets in colorectal cancer”

Total amount: 60.000 €

2015/2016

 

Dr. Sonia-Vanina Forcales Fernández

Institut de Medicina Predictiva i Personalitzada del Càncer (IMPPC- Badalona)

Identification of chromatin biomarkers for predicting and sensitizing response to current treatments in colorectal cancer.

Total amount: 60.000 €

 

Dr. Nabil Djouder

Centro Nacional de Investigaciones Oncológicas (CNIO- Madrid)

Understanding the role of growth factors and nutrients in inflammatory bowell disease and colon cancer

Total amount: 60.000 €

2014/2015

 

Dr. Raquel Batlle

Institute for Research in Biomedicine (IRB Barcelona)

Contribution of p38 MAPK signaling to colitis-associated colorectal tumorigenesis.

Total amount: 60.000 €

 

Dr. Holger Heyn

Institut d’Investigació Biomèdica de Bellvitge IDIBELL

Systems Colorectal Cancer Genomics

Total amount: 60.000 €

2013/2014


Dr. Enza Lonardo

Institute for Research in Biomedicine (IRB Barcelona)

Molecular characterization and targeted elimination of the TGF-beta-driven metastasis niche by colorectal cancer vstem cells (CRC-SCs ).

Total amount: 60.000 €

 

Dr. Mireia Jordà Ramos

Institut de Medicina Predictiva i Personalitzada del Càncer. IMPPC.

Disruption of repeat DNA epigenetic signatures as an oncogenic mechanism: uncovering  a new source of biomarkers in colorectal cancer.

Total amount: 60.000 €

2012/2013


Dr. Anna Martínez Cardús

Cancer Epigenetics Group. IDIBELL

Study of epigenetic modifications at the onset of liver metastases. Potential applicability as predictive factors of relapse.

Total amount: 60.000 €

 

Dr. Jelena Urosevic

Institute for Research in Biomedicine (IRB Barcelona)

Identification and characterization of genes associated with metastasis of colorectal cancer

Total amount: 60.000 €

2011/2012:


Dr. Anna Merlos Suàrez

Institute for Research in Biomedicine (IRB Barcelona)

Mother cells in colorectal cancer: Characterization and therapeutic approach.

Total amount: 60.000 €

 

Dr. Marta Crous Bou

Biomarker and susceptibility Unit. IDIBELL

Validation of new biomarkers for preventive diagnosis of colorectal cancer.

Total amount: 60.000 €

2010/2011:


Dr. Clara Ruiz Ponte

Galician Public Foundation of Genomic Medicine. (Santiago de Compostela)

Nine genetic variants of susceptibility to colorectal cancer: pangenomic association study, replication of results and correlation with clinical variables. 

Total amount: 60.000 €

 

Dr. Meritxell Gironella Cos

CIBERehd. Hospital Clínico (Barcelona)

Analysis of expression profiles of microRNAs in the non-invasive diagnosis of colonic neoplastic lesions.

Total amount: 60.000 €

2009/2010:


Dr.  Maria Verónica Dávalos Vega

Cancer Epigenetics Group IDIBELL, Hospital Duran i Reynals (L’Hospitalet de Llobregat)

Study on the relationship  between epigenome and microRNAs in colorectal cancer.

Total amount: 60.000 €

 

Dr. Antonio Postigo

IDIBAPS Group (Hospital Clínic Barcelona)

Transcriptional regulation of E-cadherin and invasive and metastatic capacity of tumours of the colon.

Total amount: 60.000 €

2008/2009:


Dr. Stephan Tenbaum

Stem Cell and Cancer Research Group (Vall d’Hebron Institute of Oncology, VHIO, Barcelona)

Tumor stem cells in cancer of the colon.

Total amount: 60.000 €


Dr. Eva Martínez Balibrea

Laboratory Research Group of the Research Institute in Health Sciences (Germans Trias i Pujol University Hospital.  ICO-Badalona)

Study of the role of  pyruvate kinase  m2 isoform (PK-M2) in the response and resistence to exaliplatine in cells lines and patients with advanced colorectal cancer.

Total amount: 60.000 €

2007/2008:


Dr. Sergi Castellvi Bell

Gastrointestinal Oncology Group (Hospital Clínico, Barcelona)

Susceptibility polymorphisms to colorectal cancer: Characterisation of common genetic and low penetrance in chromosomal region components 3q21-q35".

Total amount: 60.000 €

2006/2007:


Team led by Professor Dr Josep Mª Ramon

Hospital de Bellvitge (Barcelona)

D Vitamin and colorectal cancer

Total amount: 36.000 €

2005/2006:


Team led by Professor Dr Mariano Monzó

Hospital Clínico (Barcelona)

Study of marker Stem cells in colorectal cancer

Total amount: 36.000 €